Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
8
×
glaxosmithkline
8
×
life sciences
8
×
national blog main
national top stories
startups
8
×
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
amgen
cancer
cancer immunotherapy
eli lilly
fda
merck
abbvie
biogen
What
roundup
bio
disease
drug
new
adds
alliance
black
companies
crispr
diamond’s
earlier
medicines
nash
news
therapeutics
according
acquisitions
address
ago
akcea
albert
allosteric
appetite
approval
areas
biggest
biogen’s
biopharmaceutical
biosciences
biotech
bio’s
bourla
bread
brii
bristol
butter
buy
buyout
calls
Language
unset
unknown
Current search:
glaxosmithkline
×
startups
×
" boston top stories "
×
" life sciences "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline